Loading...
Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
Cytotoxic chemotherapy agents (e.g., cisplatin) are the first-line drugs to treat non-small cell lung cancer (NSCLC) but NSCLC develops resistance to the agent, limiting therapeutic efficacy. Despite many approaches to identifying the underlying mechanism for cisplatin resistance, there remains a la...
Na minha lista:
Udgivet i: | Cell Death Dis |
---|---|
Main Authors: | , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Nature Publishing Group
2017
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5520727/ https://ncbi.nlm.nih.gov/pubmed/28518145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.210 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|